Tamoxifen Market Analysis

Tamoxifen Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Tamoxifen market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Tamoxifen market.


Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment.

Tamoxifen also used in the other treatments like McCune-Albright syndrome, Infertility, Gynecomastia, Angiogenesis, Gene Expression, Riedel’s Thyroiditis.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Tamoxifen Market:
Global Industry Analysis and Opportunity Assessment 2015 - 2025
Tamoxifen belongs to selective estrogen receptor modulators (SERMs) class of drugs, which is having both estrogenic and anti-estrogenic effects. Tamoxifen has the same nucleus as diethylstilbestrol but possesses an additional side chain (Trans-isomer) which accounts for its anti-estrogenic activity.

Tamoxifen is a non-steroidal agent that binds to estrogen receptors (ER), causes a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. The prolonged binding of Tamoxifen to the nuclear chromatin of these results in reduced DNA polymerase activity, impaired thymidine utilization, blockade of estradiol uptake, and decreased estrogen response.

Tamoxifen is available in the form of tablet, Capsule and oral solution. Tablets are available in 10mg and 20mg sizes.

Tamoxifen Market: Drivers and Restraints

In the world Breast cancer is the most common cancer. Breast cancer is the second most common after the lung cancer. For the treatment of this cancer Tamoxifen is one of the choice. Increasing the cancer prevalence rate in developed countries and encouragement of government organizations like WHO (World Health Organization), American Cancer Institute in the prevention are driven the Tamoxifen Market. Governments of different countries also spreading awareness about breast cancer in the people.

However, the use of Tamoxifen is contra indicated in Pregnancy women. It has adverse effects like change in vaginal discharge, Anxiety, confusion, painful or difficult urination.

Tamoxifen Market: Segmentation

Global Tamoxifen is further segmented into following types

Tamoxifen Market: Overview

Rapid increase in prevalence rate and government organizations role in prevention of rate and awareness about the cancer in people are increases the market and is expected to have a double digit growth in the forecast period (2015-2025).

Tamoxifen Market: Region- wise Outlook             

Depending on geographic regions, the global Tamoxifen Market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

The use of Tamoxifen Market is high in North America because it is having high prevalence rate in cancer, having good healthcare setup and people are having good awareness about health care. In Asia pacific region china and India also having rapid growth health care set up and the use of Tamoxifen. Europe also having good growth in this market.

Tamoxifen Market: Key Players

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Competitive Positioning Matrix

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.



Average Selling Price (ASP) Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Based on Product

  • Tablet
  • Powder
  • Capsule
  • Oral solution

Based on Application

  • Breast Cancer
  • Other Application (McCune-Albright syndrome, Infertility, Gynecomastia, Angiogenesis, Gene Expression, Riedel’s Thyroiditis)

Based on Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific EXCL. Japan
  • Middle East and Africa
  • Japan

Some of the key players in Global Tamoxifen are

  • AstraZeneca
  • Teva pharmaceuticals
  • Watson laboratories inc
  • Aegis pharmaceuticals inc
  • Mylan pharmaceuticals inc

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology